Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias
Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare pembrolizumab to standard of care
observation (no treatment) in controlling oral pre-malignant lesions and IENs. The safety
and tolerability of pembrolizumab will also be studied.